Home » Medtronic Says FDA OKs Expanded Indication for Cardiac Resynchronization Therapy
Medtronic Says FDA OKs Expanded Indication for Cardiac Resynchronization Therapy
Medtronic said the FDA approved an expanded indication for its cardiac resynchronization therapy with implantable cardioverter defibrillator, or CRT-D, devices.
RTTnews
RTTnews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May